Sundrug Co Ltd (SDGCF)
OTHER OTC:SDGCF
SDGCF Stock Chart & Stats
$25.96
$0.00(0.00%)
At close: 4:00 PM EDT
$25.96
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$22.13 - $36.11
Previous CloseN/A
Volume176.00
Average Volume (3M)0.00
Market Cap
$2.88B
Enterprise Value$440.09B
Total Cash (Recent Filing)$62.98B
Total Debt (Recent Filing)$44.22B
Price to Earnings (P/E)14.1
Beta-0.01
Next Earnings
May 14, 2026EPS Estimate
-0.85Next Dividend Ex-DateN/A
Dividend Yield3.31%
Share Statistics
EPS (TTM)0.48
Shares Outstanding119,331,184
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio2.88
Price to Book (P/B)1.83
Price to Sales (P/S)0.61
P/FCF Ratio63.83
Enterprise Value/Market Cap152.94
Enterprise Value/Revenue0.54
Enterprise Value/Gross Profit2.16
Enterprise Value/Ebitda6.92
Forecast
1Y Price Target
$30.42Price Target Upside17.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)1.7
Revenue Forecast (FY)$5.32B
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Equity BaseA very low debt-to-equity ratio (0.14) and a high equity ratio (~60.7%) provide durable financial flexibility. This capital structure supports investment in stores, pharmacy footprint expansion and weathering demand shocks without relying on market debt issuance, preserving long-term strategic optionality.
Consistent Revenue And Profit GrowthMulti-year revenue growth around mid-single digits indicates steady underlying demand for drugstore and pharmacy offerings. Consistent top-line and profit expansion reflect durable retail fundamentals, predictable cash flows, and the ability to fund incremental store investment and service penetration over a 2–6 month horizon and beyond.
Strong Cash Generation MetricsRobust operating cash flow and a large recent rise in free cash flow show the business converts sales into cash effectively. Reliable cash generation supports dividends, capex for store upgrades or pharmacy services, and reduces reliance on external financing, strengthening long-term operational resilience.
Bears Say
Low Free Cash Flow ConversionA FCF-to-net-income ratio of 0.25 indicates much of reported profit is not yet translating into free cash, limiting capacity for sustained capex, M&A or higher shareholder distributions. Over time this gap can constrain strategic investments and reduce financial optionality despite strong operating cashflow trends.
Relatively Thin Net Profit MarginA sub-4% net margin is modest for sustaining investment and absorbing cost shocks. In a low-margin retail environment, inflation, competitive pricing or higher labor costs can quickly erode profitability, making long-term earnings more sensitive to operational and input-cost fluctuations.
Exposure To Reimbursement And Regulatory RiskA meaningful portion of revenue depends on pharmacy dispensing and reimbursement rules. Structural changes to government pricing, dispensing fees or reimbursement policies in Japan can materially affect revenue and margins for years, creating regulatory risk that is persistent rather than transient.
Sundrug Co News
SDGCF FAQ
What was Sundrug Co Ltd’s price range in the past 12 months?
Sundrug Co Ltd lowest stock price was $22.13 and its highest was $36.11 in the past 12 months.
What is Sundrug Co Ltd’s market cap?
Sundrug Co Ltd’s market cap is $2.88B.
When is Sundrug Co Ltd’s upcoming earnings report date?
Sundrug Co Ltd’s upcoming earnings report date is May 14, 2026 which is in 50 days.
How were Sundrug Co Ltd’s earnings last quarter?
Sundrug Co Ltd released its earnings results on Feb 12, 2026. The company reported $0.483 earnings per share for the quarter, missing the consensus estimate of $0.524 by -$0.041.
Is Sundrug Co Ltd overvalued?
According to Wall Street analysts Sundrug Co Ltd’s price is currently Undervalued.
Does Sundrug Co Ltd pay dividends?
Sundrug Co Ltd pays a Semiannually dividend of $0.42 which represents an annual dividend yield of 3.31%. See more information on Sundrug Co Ltd dividends here
What is Sundrug Co Ltd’s EPS estimate?
Sundrug Co Ltd’s EPS estimate is -0.85.
How many shares outstanding does Sundrug Co Ltd have?
Sundrug Co Ltd has 119,331,184 shares outstanding.
What happened to Sundrug Co Ltd’s price movement after its last earnings report?
Sundrug Co Ltd reported an EPS of $0.483 in its last earnings report, missing expectations of $0.524. Following the earnings report the stock price went down -0.831%.
Which hedge fund is a major shareholder of Sundrug Co Ltd?
Currently, no hedge funds are holding shares in SDGCF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sundrug Co Ltd
Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It also operates discount stores that offers food, cosmetics, home appliances, clothing, car supplies, sports and goods, alcoholic beverages, and pharmaceutical products, as well as fresh food, kerosene, etc. The company was founded in 1957 and is headquartered in Fuchu, Japan.
SDGCF Stock 12 Month Forecast
Average Price Target
$30.42
▲(17.20% Upside)
Technical Analysis
Sugi Holdings Co
―
TSURUHA Holdings
―
Create SD Holdings Co., Ltd.
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Ownership Overview
―
Insiders
4.83% Mutual Funds
― Other Institutional Investors
92.11% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---